drugset / Trial / NCT06841315
A Varegacestat Hepatic Impairment Study
NaSingle-groupOpen-labelOther
Summary
This clinical trial is designed to determine the pharmacokinetics, safety and tolerability of varegacestat in people with impaired liver function compared to people with normal liver function.
Timeline
- Start
- 2025-03-07
- Primary completion
- 2025-11-05
- Completion
- 2026-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | varegacestat | Small molecule | — | Oral |
Indications
No indication recorded.